We are live on ! Find out more
WSL

Western Standard LLC Portfolio holdings

AUM $190M
1-Year Est. Return 40.88%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+40.88%
3 Year Est. Return
+68.87%
5 Year Est. Return
+221.93%
10 Year Est. Return
AUM
$116M
AUM Growth
+$17.5M
Cap. Flow
+$211M
Cap. Flow %
181.79%
Top 10 Hldgs %
77.33%
Holding
45
New
20
Increased
7
Reduced
3
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 35.46%
2 Energy 16.89%
3 Consumer Staples 14.01%
4 Materials 9.05%
5 Consumer Discretionary 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MACK
1
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$20.6M 17.72%
1,672,463
VTOL icon
2
Bristow Group
VTOL
$1.37B
$19.6M 16.89%
682,532
+222,637
+48% +$5.31M
ECVT icon
3
Ecovyst
ECVT
$1.34B
$9.96M 8.58%
869,515
+12,359
+1% +$135K
DOLE icon
4
Dole
DOLE
$1.34B
$9.34M 8.04%
690,606
+9,816
+1% +$126K
PLOW icon
5
Douglas Dynamics
PLOW
$1.04B
$6.81M 5.86%
+227,849
New +$6.69M
RLJ.PRA icon
6
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$323M
$5.85M 5.04%
+242,828
New +$5.8M
HSTM icon
7
HealthStream
HSTM
$814M
$5.78M 4.98%
235,409
+46,678
+25% +$1.16M
IRTC icon
8
iRhythm Holdings
IRTC
$3.69B
$4.46M 3.84%
+42,762
New +$5.13M
GPGI
9
GPGI Inc
GPGI
$4.12B
$3.88M 3.34%
681,032
+9,680
+1% +$58K
TPB icon
10
Turning Point Brands
TPB
$1.52B
$3.53M 3.04%
+147,094
New +$3.31M
VGR
11
DELISTED
Vector Group Ltd.
VGR
$3.4M 2.93%
265,418
+3,924
+2% +$48.4K
CASH icon
12
Pathward Financial
CASH
$1.82B
$2.97M 2.56%
64,150
+4,184
+7% +$188K
GEN icon
13
Gen Digital
GEN
$16.1B
$2.38M 2.05%
128,513
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.22M 1.91%
+21,600
New +$2.28M
CYT
15
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$1.36M 1.17%
+524,050
New +$1.1M
ORKA
16
Oruka Therapeutics
ORKA
$5.44B
$1.28M 1.1%
+52,516
New +$1.29M
NBN icon
17
Northeast Bank
NBN
$1.14B
$1.22M 1.05%
+29,300
New +$1.11M
BVS icon
18
Bioventus
BVS
$843M
$1.15M 0.99%
+396,316
New +$761K
UBS icon
19
UBS Group
UBS
$172B
$1.11M 0.96%
+55,000
New +$1.11M
SPHR icon
20
Sphere Entertainment
SPHR
$5.01B
$1.08M 0.93%
+39,600
New +$1.31M
TIL icon
21
Instil Bio
TIL
$48.5M
$990K 0.85%
89,849
ABEO icon
22
Abeona Therapeutics
ABEO
$349M
$903K 0.78%
224,151
PRDS
23
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$874K 0.75%
+482,874
New +$883K
NGNE icon
24
Neurogene
NGNE
$691M
$715K 0.62%
+43,044
New +$706K
MX icon
25
Magnachip Semiconductor
MX
$126M
$648K 0.56%
+57,935
New +$567K

Similar funds

Western Standard LLC's Q2 2023 Portfolio in Review

As of Q2 2023, Western Standard LLC held 45 positions worth $116M, up 18% from $98.6M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Western Standard LLC deployed $211M of net new capital in Q2 2023, opening 20 new positions and adding to 7 existing holdings. Its largest new stake was Douglas Dynamics: 227,849 shares worth $6.81M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 43% a quarter earlier, followed by Energy and Consumer Staples.

On the sell side, the largest reduction was LENZ Therapeutics, an estimated $914K trimmed.

  • Western Standard LLC's largest Q2 2023 buy was Douglas Dynamics: 227,849 shares worth $6.81M.
  • Western Standard LLC added most to Bristow Group in Q2 2023, an estimated $5.31M increase.
  • Western Standard LLC's biggest Q2 2023 reduction was LENZ Therapeutics, cutting an estimated $914K.
  • Western Standard LLC fully exited RLJ Lodging Trust in Q2 2023, selling an estimated $6.54M.
  • Western Standard LLC's ten largest holdings make up 77% of its $116M portfolio in Q2 2023.
  • Western Standard LLC opened 20 new positions and closed 10 in Q2 2023.
  • Western Standard LLC's portfolio value rose 18% quarter-over-quarter to $116M.

Based on Western Standard LLC's 13F filing for Q2 2023, filed 14 Aug 2023.